The content on this site is intended for healthcare professionals only
Dr Sofia Rivera speaks to ecancer about the pros and cons of breast intraoperative radiotherapy (IORT) and ultra hypofractionation.
She explains that for breast cancer patients they can now receive a single session of IORT during surgery following the tumour excision which most often results in post-operative radiation therapy no longer being required.
Dr Rivera concludes by outlining her thoughts on the potential future effect of IORT on the treatment of breast cancer.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Breast and emerging indications for IORT
The advantages of IORT for early breast cancer treatment
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Global adoption of single-shot targeted IORT for breast cancer
IORT at the Asian Hospital and Medical Center
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival
Insights from TARGIT-A trial of targeted IORT during lumpectomy for breast cancer
Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of muscle-invasive bladder cancer patients
